Tag: GLP-1 GIP agonist

Dec 7, 2025
Posted by Cillian Osterfield

Tirzepatide for Weight Loss: How Dual Incretin Therapy Works

Tirzepatide (Zepbound) is a dual GLP-1 and GIP agonist that helps with weight loss by targeting appetite, fat storage, and metabolism. It leads to up to 22.4% body weight loss in trials and outperforms older drugs like semaglutide.

Tag: GLP-1 GIP agonist

Tirzepatide for Weight Loss: How Dual Incretin Therapy Works

Categories

Latest Posts

How Azathioprine Works in Lupus Treatment: A Clear Guide

Motion Sickness and Anxiety: How to Manage Both Effectively

How to Transport Medications in Hot and Cold Weather: A Practical Guide for Patients and Caregivers

Multicultural Perspectives on Generics: How Culture Affects Patient Trust and Adherence

Menopause and Smoking: Why Quitting Now Makes a Difference

Tag Cloud